Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination ...

Three recalls tied to the same cannabis producer are raising questions about transparency and regulatory follow-through.

A new scale for grading ocular adverse events in oncology trials addresses ambiguities in CTCAE version 5 and includes dose modification recommendations. The scale, implemented in the I-SPY 2 trial, ...

RAD51-based assessment effectively identifies HER2-negative metastatic breast cancer patients likely to respond to olaparib, especially with BRCA1/2 or PALB2 variants. RAD51-low tumors showed a higher ...

Widespread ocean pollution threatens the health of more than 3 billion people, international study led by Boston College researchers shows Ocean pollution is widespread and getting worse, and when ...